Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

PHARMACEUTICALS

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

DIHYDRALAZINE SULFATE (HYDRATED) - REFERENCE SPECTRUM (N/A)

DIHYDRALAZINE SULFATE (HYDRATED) - REFERENCE SPECTRUM (N/A)

NA

DISCOVER
DIHYDROERGOCRISTINE MESILATE CRS (120 MG)

DIHYDROERGOCRISTINE MESILATE CRS (120 MG)

24730-10-7

DISCOVER
DIHYDROERGOTAMINE MESILATE CRS (50 MG)

DIHYDROERGOTAMINE MESILATE CRS (50 MG)

6190-39-2

DISCOVER
Dihydroergotamine tartrate

Dihydroergotamine tartrate

5989-77-5

DISCOVER
DIHYDROSTREPTOMYCIN SULFATE CRS (25 MG)

DIHYDROSTREPTOMYCIN SULFATE CRS (25 MG)

5490-27-7

DISCOVER
DILTIAZEM HYDROCHLORIDE CRS (100 MG)

DILTIAZEM HYDROCHLORIDE CRS (100 MG)

33286-22-5

DISCOVER
DIMENHYDRINATE CRS (50 MG)

DIMENHYDRINATE CRS (50 MG)

523-87-5

DISCOVER
Dopa-L

Dopa-L

59-92-7

DISCOVER
DIMETHYL SULFOXIDE CRS (1 ML)

DIMETHYL SULFOXIDE CRS (1 ML)

67-68-5

DISCOVER
Doxycycline hydrate

Doxycycline hydrate

17086-28-1

DISCOVER
Dacarbazine

Dacarbazine

04/03/4342

DISCOVER
Decitabine

Decitabine

2353-33-5

DISCOVER